Atypical Neurofibromatous Neoplasms of Uncertain Biological Potential in Children with Neurofibromatosis Type 1: Report of Two Patients and Review.

Int J Surg PatholMay 14, 2026 (epub)

Nelly Marlene Román-Mendoza, Eunate Martí-Carrera, Daniel Azorín-Cuadrillero et al.

✦ AI-curated · Sources linked

Case in brief

Two pediatric patients with Neurofibromatosis Type 1 (NF1) presented with rapidly enlarging peripheral nodules. The first patient, a 13-year-old boy, had a lumbogluteal nodule that showed growth despite treatment with selumetinib. Imaging revealed a hypoechoic lesion, and excision confirmed atypical neurofibromatous neoplasm of uncertain biological potential (ANNUBP). The second patient, a 15-year-old girl, had a painful forearm mass, and resection also revealed ANNUBP. Both patients remain recurrence-free.

Diagnostic / clinical pearl

ANNUBP in children can present with atypical features such as hypercellularity and low-level mitotic figures, necessitating careful imaging and histological evaluation for accurate diagnosis.

Why it matters

Understanding the characteristics of ANNUBP can aid in distinguishing it from more aggressive tumors like malignant peripheral nerve sheath tumors, improving management and surveillance strategies.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.